StonvexLoading…
StonvexStonvexStonvexCore line items from COHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $5.81B | $4.71B | $5.16B | $3.32B |
Operating Income | $94.18M | $96.12M | $-37.12M | $414.29M |
Net Income | $49.36M | $-156.15M | $-259.46M | $234.76M |
EPS (Diluted) | $-0.52 | $-1.84 | $-2.93 | $1.45 |
Total Assets | $14.91B | $14.49B | $13.71B | $7.84B |
Total Liabilities | $6.43B | $6.54B | $6.48B | $3.46B |
Cash & Equivalents | $909.20M | $926.03M | $821.31M | $2.58B |
Free Cash Flow OCF − CapEx | $192.76M | $198.91M | $197.97M | $99.00M |
Shares Outstanding | 154.75M | 151.64M | 137.58M | 116.51M |